Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphon
about
Buprenorphine for treating cancer painBuprenorphine for treating cancer painOpioids for neuropathic painBuprenorphine for treating cancer painBuprenorphine for treating cancer painRole of Tapentadol Immediate Release (Nucynta) in the Management Of Moderate-to-Severe PainPharmacotherapy of Pain in the Older Population: The Place of OpioidsBuprenorphine - an attractive opioid with underutilized potential in treatment of chronic painNeuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future ProspectsThe Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A ReviewEffects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature reviewManipulating the Placebo Response in Experimental Pain by Altering Doctor's Performance StylePalliative Care in Older Patients With CancerConsiderations on the use of oxymorphone in geriatric patientsPrescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areasChronic Pain: How Challenging Are DDIs in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions?Estimating the prevalence of opioid diversion by "doctor shoppers" in the United StatesSymptom management in the older adult: 2015 updatePrimary care providers' perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative studySubcutaneous Implants of a Cholesterol-Triglyceride-Buprenorphine Suspension in RatsChronic morphine administration delays wound healing by inhibiting immune cell recruitment to the wound site.Oxycodone vs. fentanyl patient-controlled analgesia after laparoscopic cholecystectomy.Investigation and analysis of oncologists' knowledge of morphine usage in cancer pain treatment.Opioid use prior to total hip arthroplasty leads to worse clinical outcomesTramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review.Oxycodone combinations for pain relief.Pentazocine Alone Versus Pentazocine Plus Diclofenac for Pain Relief in the First 24 Hours after Caesarean Section: A Randomized Controlled StudyMethadone deaths: risk factors in pain and addicted populations.Pharmacological Approaches for the Management of Persistent Pain in Older Adults: What Nurses Need to KnowThe Link between Depression and Chronic Pain: Neural Mechanisms in the Brain.Sleep disordered breathing and chronic respiratory failure in patients with chronic pain on long term opioid therapyBuprenorphine transdermal system for opioid therapy in patients with chronic low back pain.Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patientsPain management in the elderly at the end of lifeCannabis in palliative medicine: improving care and reducing opioid-related morbidity.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.The management of chronic pain in important patient subgroups.Guidance on the management of pain in older people.Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells.Effects of chronic fentanyl administration on physical performance of aged rats
P2860
Q24187076-AB51C35C-DB78-46CE-9800-150ADCDAF3E9Q24197553-1D385A4D-4E93-46EF-A92E-F0BC710D8F04Q24200179-86EC1588-77D1-4A60-8839-18A9A7B05A98Q24202194-C0F2C201-5F02-46E4-B93E-13B528BFE9A7Q24204011-F655DE41-7D2C-4D40-91AC-1D4446D9907CQ24632728-97D9672D-1E58-424B-B7A0-3931B2941E42Q26744640-D07F7636-FE3B-48A9-87C5-7508BA2018C1Q26775658-0D275757-086C-4DA4-9F52-BC3BCB743D95Q26799409-053AD199-D754-431B-BC9D-EFE8E60032A0Q26851158-6678E6DC-45AF-4B99-B13F-80BE42D3EDCEQ26860175-06CF26F9-9D7D-49E6-ADB4-2CF08F53842FQ27304510-70067906-42F5-4A83-A4B1-D38B65FE235EQ28085144-F701AF66-7692-4654-BE92-3E7A907BBB8BQ28252394-803B5C3D-B654-476B-8020-C5BA0C3D4C91Q28396203-EBE6FC30-692B-4759-AAFE-C45CBE4B5AE1Q28468436-035F0C88-1145-4B3B-B2D0-0E15C77A2F41Q28534694-CF472390-6812-442E-8ECD-28BFB0225AF6Q30374202-C843D157-E0F2-4F7F-8B89-FF2C410BA98EQ31022925-F1823FC0-C99C-4D3D-A661-1E31AF6BDA67Q33592944-58698250-D051-4555-BF84-F2FDAFE20F1EQ33597153-2AA6D930-F7E8-492E-B346-252515D00D06Q33628410-A8E62E78-C868-4681-A724-F92A6B0A8C19Q33680251-51D537AA-5F96-4F89-9DA3-51062C48176FQ33681344-00F0D4C9-0C72-4382-AA02-E7F672CD4066Q33697613-1DCA0B4C-55EA-4568-88C4-5E8C9D1203BDQ33713626-4CC6178F-78FA-4C2A-8E4A-ADFA9D9E9A35Q33741810-E4B70084-1B55-45E1-8704-C24F16802BC8Q33742582-0DD87EBA-B07D-44C8-82AE-48C8A41769FAQ33803025-71634269-9850-4B6B-884C-2836886ABDC7Q33863747-4BA14CCD-1B80-4145-AC55-3BA7DACEC22DQ33933745-DD6FAA74-1F20-481F-AF21-68E9B4B1E569Q34030400-919D948A-5D74-4D87-B0EA-785B66AE5773Q34068571-1FDBBBCE-822B-4F0E-95C1-356D9F647975Q34101629-3FB94AB3-658C-4489-A653-2BEDE47C901CQ34173898-E30D6276-50B1-47BC-88BC-CE2BFF83D4AAQ34277168-2BE723DE-0F93-4D8A-A8A6-644F72A66A3EQ34326675-234749E6-4A9D-4204-8FBC-1EF96C544CAEQ34328425-9AE2E932-D033-4D45-90B1-B5CF09AE7CACQ34359979-C332BB3C-50E8-48DD-88E5-0CB8378848CCQ34388559-D59947E2-8B16-483C-8E5F-E55DB79CE680
P2860
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphon
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@ast
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@en
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@nl
type
label
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@ast
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@en
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@nl
prefLabel
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@ast
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@en
Opioids and the management of ...... rphine, fentanyl, hydromorphon
@nl
P2093
P921
P1433
P1476
Opioids and the management of ...... ethadone, morphine, oxycodone)
@en
P2093
Albert Dahan
Hans-Georg Kress
Joseph Pergolizzi
Keith Budd
Paola Sacerdote
Rainer H Böger
Richard Langford
Robert B Raffa
Rudolf Likar
Serdar Erdine
P304
P356
10.1111/J.1533-2500.2008.00204.X
P50
P577
2008-05-23T00:00:00Z